Cargando…
Therapeutic Potential of 1,8-Dihydroanthraquinone Derivatives for Breast Cancer
Breast cancer (BC) is the most common malignancy among women worldwide. In recent years, significant progress has been made in BC therapy. However, serious side effects resulting from the use of standard chemotherapeutic drugs, as well as the phenomenon of multidrug resistance (MDR), limit the effec...
Autores principales: | Okon, Estera, Gaweł-Bęben, Katarzyna, Jarzab, Agata, Koch, Wojciech, Kukula-Koch, Wirginia, Wawruszak, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648492/ https://www.ncbi.nlm.nih.gov/pubmed/37958772 http://dx.doi.org/10.3390/ijms242115789 |
Ejemplares similares
-
Advances in Chemistry and Bioactivity of Magnoflorine and Magnoflorine-Containing Extracts
por: Okon, Estera, et al.
Publicado: (2020) -
Valproic Acid and Breast Cancer: State of the Art in 2021
por: Wawruszak, Anna, et al.
Publicado: (2021) -
Synergistic or Additive Pharmacological Interactions between Magnoflorine and Cisplatin in Human Cancer Cells of Different Histological Origin
por: Okon, Estera, et al.
Publicado: (2020) -
Vorinostat (SAHA) and Breast Cancer: An Overview
por: Wawruszak, Anna, et al.
Publicado: (2021) -
Emodin-8-O-Glucoside—Isolation and the Screening of the Anticancer Potential against the Nervous System Tumors
por: Okon, Estera, et al.
Publicado: (2023)